Clinical Trials Browser

Mesothelioma, Malignant × Dasatinib × Other solid neoplasm × Clear all

NCT00652574 2022-10-31

Dasatinib in Resectable Malignant Pleural Mesothelioma

Phase 1 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT00509041 2016-08-11

Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma

Phase 2 Completed

46 enrolled 14 charts

Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural